All News #Library
Biotech
Neuraptive Enrolls First Patient in Ph 3 NTX-001 Nerve Trial
02 Oct 2025 //
PHARMAWEB
Neuraptive Announces Positive 24-Week Data for NTX-001 in the Phase 2 Study
22 Feb 2024 //
BUSINESSWIRE
Neuraptive Announces Achievement of Proof of Concept in The Study of NTX-001
08 Jan 2024 //
BUSINESSWIRE

Market Place
Sourcing Support